Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

396 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Liver MR imaging: 1.5T versus 3T.
Ramalho M, Altun E, Herédia V, Zapparoli M, Semelka R. Ramalho M, et al. Magn Reson Imaging Clin N Am. 2007 Aug;15(3):321-47, vi. doi: 10.1016/j.mric.2007.06.003. Magn Reson Imaging Clin N Am. 2007. PMID: 17893053 Review.
A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in patients with liver pathology: results of a Phase III clinical trial.
Rubin DL, Desser TS, Semelka R, Brown J, Nghiem HV, Stevens WR, Bluemke D, Nelson R, Fultz P, Reimer P, Ho V, Kristy RM, Pierro JA. Rubin DL, et al. J Magn Reson Imaging. 1999 Feb;9(2):240-50. doi: 10.1002/(sici)1522-2586(199902)9:2<240::aid-jmri14>;2-#. J Magn Reson Imaging. 1999. PMID: 10077020 Clinical Trial.
Prosthetic testicle: appearance at MR imaging.
Semelka R, Anderson M, Hricak H. Semelka R, et al. Radiology. 1989 Nov;173(2):561-2. doi: 10.1148/radiology.173.2.2798890. Radiology. 1989. PMID: 2798890
Gadolinium toxicity and treatment.
Ramalho J, Ramalho M, Jay M, Burke LM, Semelka RC. Ramalho J, et al. Among authors: semelka rc. Magn Reson Imaging. 2016 Dec;34(10):1394-1398. doi: 10.1016/j.mri.2016.09.005. Epub 2016 Sep 28. Magn Reson Imaging. 2016. PMID: 27693607 Review.
396 results